Liver resection for hepatolithiasis: A multicenter experience in Latin America.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
02 2023
Historique:
received: 07 03 2022
revised: 19 10 2022
accepted: 22 10 2022
pubmed: 3 12 2022
medline: 1 2 2023
entrez: 2 12 2022
Statut: ppublish

Résumé

Hepatolithiasis is a prevalent disease in Asia but rare in Western countries. An increasing number of cases have been reported in Latin America. Liver resection has been proposed as a definitive treatment for complete stone clearance. The aim of this study was to evaluate the postoperative outcomes of liver resection for the treatment of hepatolithiasis in 2 large hepatobiliary reference centers from South America. We conducted a retrospective descriptive analysis from patients with hepatolithiasis who underwent liver resection between November 1986 and December 2018, in 2 Latin-American centers in Chile and Brazil. One hundred forty-nine patients underwent liver resection for hepatolithiasis (72 in Chile, 77 in Brazil). The mean age was 49 years and most patients were female (62.4%). Hepatolithiasis was localized in the left lobe (61.7%), right lobe (24.2%), and bilateral lobe (14.1%). Bilateral lithiasis was associated with higher incidence of preoperative and postoperative cholangitis (81% vs 46.9% and 28.6% vs 6.1%) and need for hepaticojejunostomy (52.4%). In total, 38.9% of patients underwent major hepatectomy and 14.1% were laparoscopic. The postoperative stone clearance was 100%. The 30-day morbidity and mortality rates were 30.9% and 0.7%, respectively. Cholangiocarcinoma was seen in 2 specimens, and no postoperative malignancy were seen after a median follow-up of 38 months. Fourteen patients (9.4%) had intrahepatic stones recurrence. Liver resection is an effective and definitive treatment for patients with hepatolithiasis. Bilateral hepatolithiasis was associated with perioperative cholangitis, the need for hepaticojejunostomy, and recurrent disease. Resection presents a high rate of biliary tree stone clearance and excellent long-term results, with low recurrence rates and low risk of malignancy.

Sections du résumé

BACKGROUND
Hepatolithiasis is a prevalent disease in Asia but rare in Western countries. An increasing number of cases have been reported in Latin America. Liver resection has been proposed as a definitive treatment for complete stone clearance. The aim of this study was to evaluate the postoperative outcomes of liver resection for the treatment of hepatolithiasis in 2 large hepatobiliary reference centers from South America.
METHODS
We conducted a retrospective descriptive analysis from patients with hepatolithiasis who underwent liver resection between November 1986 and December 2018, in 2 Latin-American centers in Chile and Brazil.
RESULTS
One hundred forty-nine patients underwent liver resection for hepatolithiasis (72 in Chile, 77 in Brazil). The mean age was 49 years and most patients were female (62.4%). Hepatolithiasis was localized in the left lobe (61.7%), right lobe (24.2%), and bilateral lobe (14.1%). Bilateral lithiasis was associated with higher incidence of preoperative and postoperative cholangitis (81% vs 46.9% and 28.6% vs 6.1%) and need for hepaticojejunostomy (52.4%). In total, 38.9% of patients underwent major hepatectomy and 14.1% were laparoscopic. The postoperative stone clearance was 100%. The 30-day morbidity and mortality rates were 30.9% and 0.7%, respectively. Cholangiocarcinoma was seen in 2 specimens, and no postoperative malignancy were seen after a median follow-up of 38 months. Fourteen patients (9.4%) had intrahepatic stones recurrence.
CONCLUSIONS
Liver resection is an effective and definitive treatment for patients with hepatolithiasis. Bilateral hepatolithiasis was associated with perioperative cholangitis, the need for hepaticojejunostomy, and recurrent disease. Resection presents a high rate of biliary tree stone clearance and excellent long-term results, with low recurrence rates and low risk of malignancy.

Identifiants

pubmed: 36460528
pii: S0039-6060(22)00896-0
doi: 10.1016/j.surg.2022.10.024
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-304

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Daniel García (D)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: https://twitter.com/DanielGOneto.

Carlo Marino (C)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Fabricio Ferreira Coelho (F)

Digestive Surgery Division, Department of Gastroenterology, Hospital das Clinicas, Instituto do Câncer do Estado de São Paulo, University of São Paulo School of Medicine, Brazil.

Patricia Rebolledo (P)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Pablo Achurra (P)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Gilton Marques Fonseca (G)

Digestive Surgery Division, Department of Gastroenterology, Hospital das Clinicas, Instituto do Câncer do Estado de São Paulo, University of São Paulo School of Medicine, Brazil.

Jaime A P Kruger (JAP)

Digestive Surgery Division, Department of Gastroenterology, Hospital das Clinicas, Instituto do Câncer do Estado de São Paulo, University of São Paulo School of Medicine, Brazil.

Eduardo Viñuela (E)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Eduardo Briceño (E)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Luiz Carneiro D'Albuquerque (L)

Digestive Surgery Division, Department of Gastroenterology, Hospital das Clinicas, Instituto do Câncer do Estado de São Paulo, University of São Paulo School of Medicine, Brazil.

Nicolas Jarufe (N)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Jorge A Martinez (JA)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Paulo Herman (P)

Digestive Surgery Division, Department of Gastroenterology, Hospital das Clinicas, Instituto do Câncer do Estado de São Paulo, University of São Paulo School of Medicine, Brazil.

Martin J Dib (MJ)

Department of Digestive Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: dibmartin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH